TRENDS IN THE USE OF SECOND-GENERATION ANDROGEN RECEPTOR AXIS INHIBITORS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER AND CLINICAL FACTORS PREDICTING BIOLOGICAL RECURRENCE

被引：0
|
作者：
Nakane, Keita
Watanabe, Hiromitsu
Naiki, Taku
Takahara, Kiyoshi
Yasui, Takahiro
Miyake, Hideaki
Shiroki, Ryoichi
Koie, Takuya
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP60-09
引用
收藏
页码：E1002 / E1003
页数：2
相关论文
共 50 条
  • [1] Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence
    Nakane, Keita
    Watanabe, Hiromitsu
    Naiki, Taku
    Takahara, Kiyoshi
    Yasui, Takahiro
    Miyake, Hideaki
    Shiroki, Ryoichi
    Koie, Takuya
    DIAGNOSTICS, 2023, 13 (09)
  • [2] Screening for Predictive Factors of Efficacy of Second-Generation Androgen Receptor Axis-Targeted Agents in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
    Ueda, Takashi
    Hayakawa, Keita
    Horiguchi, Go
    Murashita, Junki
    Shiraishi, Takumi
    Fujimoto, Saizo
    Miyashita, Masatsugu
    Saito, Yumiko
    Gabata, Yusuke
    Sako, Satoshi
    Takahashi, Hikaru
    Fujihara, Atsuko
    Minami, Takafumi
    Yamamoto, Yutaka
    Okumi, Masayoshi
    Hongo, Fumiya
    Okihara, Koji
    Fujita, Kazutoshi
    Ukimura, Osamu
    PROSTATE, 2025,
  • [3] Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer
    Crisafi, Daniel
    Wong, Benjamin Ngie Xiong
    Bolton, Damien
    Ischia, Joseph
    Woon, Dixon
    BJU INTERNATIONAL, 2024, 134 : 12 - 13
  • [4] Clinical use and outcomes of androgen-receptor pathway inhibitors triplet therapy for metastatic hormone-sensitive prostate cancer (ARAAT).
    McKay, Rana R.
    Morgans, Alicia K.
    Khan, Nasreen
    Constantinovici, Niculae
    Chen, Guifang
    Ghadessi, Mercedeh
    Appukkuttan, Sreevalsa
    Jhaveri, Jay
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [5] Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancer
    Hahn, Andrew W.
    Hale, Peter
    Rathi, Nityam
    Agarwal, Neeraj
    CURRENT OPINION IN UROLOGY, 2017, 27 (06) : 559 - 565
  • [6] Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors
    Suzuki, Kotaro
    Shiraishi, Yusuke
    Furukawa, Junya
    Okamura, Yasuyoshi
    Bando, Yukari
    Hara, Takuto
    Okada, Keisuke
    Terakawa, Tomoaki
    Hyodo, Yoji
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [7] Novel androgen receptor inhibitors for metastatic hormone-sensitive prostate cancer: Current application and future perspectives
    Xia, Qi-Dong
    Zhang, Si-Han
    Zeng, Na
    Lu, Yu-Chao
    Qin, Bao-Long
    Wang, Shao-Gang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [8] Rezvilutamide: yet another androgen receptor pathway inhibitor for metastatic hormone-sensitive prostate cancer?
    Aragon-Ching, Jeanny B.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [9] Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors
    Yamada, Yasutaka
    Sato, Kodai
    Sakamoto, Shinichi
    Tsujino, Takuya
    Saito, Sinpei
    Nishimura, Kazuki
    Fukushima, Tatsuo
    Nakamura, Ko
    Yoshikawa, Yuki
    Matsunaga, Tomohisa
    Maenosono, Ryoichi
    Kanesaka, Manato
    Arai, Takayuki
    Sazuka, Tomokazu
    Imamura, Yusuke
    Komura, Kazumasa
    Mikami, Kazuo
    Nakamura, Kazuyoshi
    Fukasawa, Satoshi
    Chiba, Kazuto
    Naya, Yukio
    Nagata, Maki
    Komaru, Atsushi
    Nakatsu, Hiroomi
    Azuma, Haruhito
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (03) : 539 - 550
  • [10] Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
    Fiorica, Francesco
    Buttigliero, Consuelo
    Grigolato, Daniela
    Muraro, Marco
    Turco, Fabio
    Munoz, Fernando
    Tucci, Marcello
    CURRENT ONCOLOGY, 2022, 29 (12) : 9511 - 9524
12345